These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 26147011)

  • 1. Glycogen synthase kinase-3 inhibitor AR-A014418 suppresses pancreatic cancer cell growth via inhibition of GSK-3-mediated Notch1 expression.
    Kunnimalaiyaan S; Gamblin TC; Kunnimalaiyaan M
    HPB (Oxford); 2015 Sep; 17(9):770-6. PubMed ID: 26147011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Specific glycogen synthase kinase-3 inhibition reduces neuroendocrine markers and suppresses neuroblastoma cell growth.
    Carter YM; Kunnimalaiyaan S; Chen H; Gamblin TC; Kunnimalaiyaan M
    Cancer Biol Ther; 2014 May; 15(5):510-5. PubMed ID: 24521712
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aberrant nuclear accumulation of glycogen synthase kinase-3beta in human pancreatic cancer: association with kinase activity and tumor dedifferentiation.
    Ougolkov AV; Fernandez-Zapico ME; Bilim VN; Smyrk TC; Chari ST; Billadeau DD
    Clin Cancer Res; 2006 Sep; 12(17):5074-81. PubMed ID: 16951223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Maintenance of constitutive IkappaB kinase activity by glycogen synthase kinase-3alpha/beta in pancreatic cancer.
    Wilson W; Baldwin AS
    Cancer Res; 2008 Oct; 68(19):8156-63. PubMed ID: 18829575
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glycogen synthase kinase-3beta participates in nuclear factor kappaB-mediated gene transcription and cell survival in pancreatic cancer cells.
    Ougolkov AV; Fernandez-Zapico ME; Savoy DN; Urrutia RA; Billadeau DD
    Cancer Res; 2005 Mar; 65(6):2076-81. PubMed ID: 15781615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glycogen synthase kinase-3 inhibition disrupts nuclear factor-kappaB activity in pancreatic cancer, but fails to sensitize to gemcitabine chemotherapy.
    Mamaghani S; Patel S; Hedley DW
    BMC Cancer; 2009 Apr; 9():132. PubMed ID: 19405981
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Xanthohumol-Mediated Suppression of Notch1 Signaling Is Associated with Antitumor Activity in Human Pancreatic Cancer Cells.
    Kunnimalaiyaan S; Trevino J; Tsai S; Gamblin TC; Kunnimalaiyaan M
    Mol Cancer Ther; 2015 Jun; 14(6):1395-403. PubMed ID: 25887885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential Role of Glycogen Synthase Kinase-3β in Regulation of Myocardin Activity in Human Vascular Smooth Muscle Cells.
    Zhou YX; Shi Z; Singh P; Yin H; Yu YN; Li L; Walsh MP; Gui Y; Zheng XL
    J Cell Physiol; 2016 Feb; 231(2):393-402. PubMed ID: 26129946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Troglitazone, a PPAR agonist, inhibits human prostate cancer cell growth through inactivation of NFκB via suppression of GSK-3β expression.
    Ban JO; Oh JH; Son SM; Won D; Song HS; Han SB; Moon DC; Kang KW; Song MJ; Hong JT
    Cancer Biol Ther; 2011 Aug; 12(4):288-96. PubMed ID: 21613824
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GSK3α/β: A Novel Therapeutic Target for Neuroendocrine Tumors.
    Aristizabal Prada ET; Weis C; Orth M; Lauseker M; Spöttl G; Maurer J; Grabowski P; Grossman A; Auernhammer CJ; Nölting S
    Neuroendocrinology; 2018; 106(4):335-351. PubMed ID: 28968593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AR-A014418 as a glycogen synthase kinase-3 inhibitor: anti-apoptotic and therapeutic potential in experimental spinal cord injury.
    Tunçdemir M; Yıldırım A; Karaoğlan A; Akdemir O; Oztürk M
    Neurocirugia (Astur); 2013; 24(1):22-32. PubMed ID: 23116585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential therapeutic effect of glycogen synthase kinase 3beta inhibition against human glioblastoma.
    Miyashita K; Kawakami K; Nakada M; Mai W; Shakoori A; Fujisawa H; Hayashi Y; Hamada J; Minamoto T
    Clin Cancer Res; 2009 Feb; 15(3):887-97. PubMed ID: 19188159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of GSK-3β reverses the pro-apoptotic effect of proadifen (SKF-525A) in HT-29 colon adenocarcinoma cells.
    Jendželovský R; Koval J; Mikeš J; Papčová Z; Plšíková J; Fedoročko P
    Toxicol In Vitro; 2012 Sep; 26(6):775-82. PubMed ID: 22683934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glycogen synthase kinase 3β inhibition sensitizes pancreatic cancer cells to gemcitabine.
    Shimasaki T; Ishigaki Y; Nakamura Y; Takata T; Nakaya N; Nakajima H; Sato I; Zhao X; Kitano A; Kawakami K; Tanaka T; Takegami T; Tomosugi N; Minamoto T; Motoo Y
    J Gastroenterol; 2012 Mar; 47(3):321-33. PubMed ID: 22041920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GSK3β suppression inhibits MCL1 protein synthesis in human acute myeloid leukemia cells.
    Lee YC; Shi YJ; Wang LJ; Chiou JT; Huang CH; Chang LS
    J Cell Physiol; 2021 Jan; 236(1):570-586. PubMed ID: 32572959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glycogen synthase kinase-3 is involved in the regulation of the cell cycle in cerebellar granule cells.
    Yeste-Velasco M; Folch J; Trullàs R; Abad MA; Enguita M; Pallàs M; Camins A
    Neuropharmacology; 2007 Aug; 53(2):295-307. PubMed ID: 17612578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of Notch1/NICD and Hes1 expressions by GSK-3alpha/beta.
    Jin YH; Kim H; Oh M; Ki H; Kim K
    Mol Cells; 2009 Jan; 27(1):15-9. PubMed ID: 19214430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of glycogen synthase kinase-3 beta induces apoptosis and mitotic catastrophe by disrupting centrosome regulation in cancer cells.
    Yoshino Y; Ishioka C
    Sci Rep; 2015 Aug; 5():13249. PubMed ID: 26292722
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Flavonoid apigenin modified gene expression associated with inflammation and cancer and induced apoptosis in human pancreatic cancer cells through inhibition of GSK-3β/NF-κB signaling cascade.
    Johnson JL; de Mejia EG
    Mol Nutr Food Res; 2013 Dec; 57(12):2112-27. PubMed ID: 23943362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The antinociceptive effects of AR-A014418, a selective inhibitor of glycogen synthase kinase-3 beta, in mice.
    Martins DF; Rosa AO; Gadotti VM; Mazzardo-Martins L; Nascimento FP; Egea J; López MG; Santos AR
    J Pain; 2011 Mar; 12(3):315-22. PubMed ID: 20705523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.